Researchers Reveal Stomach Cancer Suppression Mechanism
News Aug 12, 2015
Finding drugs capable of inducing miR-7 could therefore prove to be an effective treatment against the progression of gastric cancer.
Gastric cancer is the fourth most common cancer and the third leading cause of cancer-related deaths worldwide, according to the National Institutes of Health. miR-7, which is frequently decreased in gastric cancers, can stop the cancer cells from spreading to other tissues by inhibiting a particular growth factor receptor (called IGF1R). Whether miR-7 also suppresses earlier stages of gastric cancer is unknown, however, so researchers in China screened for new targets of the microRNA.
Dai-Ming Fan and colleagues found that miR-7 directly targets the genes RELA and FOS, which encode proteins involved in the pro-oncogenic NF-κB and AP-1 signaling pathways, respectively. In human gastric cancer samples, low miR-7 levels correlated with elevated levels of RELA and FOS proteins and poor patient survival. Increasing levels of miR-7 reduced RELA and FOS levels and inhibited tumor growth in mice.
The researchers found that, as well as directly suppressing RELA expression, miR-7 could control the protein's activation by targeting its upstream kinase (IKKε) in the NF-κB pathway. Yet, this same pathway was itself able to repress miR-7 expression, indicating that miR-7 would be unable to restrain RELA's activity if the NF-κB pathway were strongly activated.
Chronic H. pylori infection is a major risk factor for gastric cancer, in part because the bacterium can hyperactivate the NF-κB pathway. Accordingly, Fan and colleagues found that culturing H. pylori with gastric cells activated IKKε and RELA, and reduced the expression of miR-7, a potentially key step in the transformation of healthy gastric cells into malignant ones.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE